Back to Search
CARRIE LEHR, M.D.
M.D.
Internal Medicine Physician
NPI: 1356390322Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.
PMID 18803262·J Pharm Sci·2009
8-other
Biological barriers and nanomedicine--timely challenges in advanced drug delivery research.
PMID 19362591·Eur J Pharm Biopharm·2009
8-other
Nortriptyline for smoking cessation: release and human skin diffusion from patches.
PMID 19501148·Int J Pharm·2009
8-other
Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
PMID 19374532·Oligonucleotides·2009
8-other
In vitro systems for studying epithelial transport of macromolecules.
PMID 19085125·Methods Mol Biol·2009
7-preclinical
The role of corneocytes in skin transport revised--a combined computational and experimental approach.
PMID 19240984·Pharm Res·2009
8-other
A novel cell compatible impingement system to study in vitro drug absorption from dry powder aerosol formulations.
PMID 18771729·Eur J Pharm Biopharm·2009
8-other
Biotransformation of arsenic by a Yellowstone thermoacidophilic eukaryotic alga.
PMID 19276121·Proc Natl Acad Sci U S A·2009
8-other
The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.
PMID 18703137·Eur J Pharm Biopharm·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10787 NALL AVE, STE. 310
OVERLAND PARK, KS 66211 - Phone
- (913) 945-6900
Quick Facts
- NPI
- 1356390322
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile